Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.39NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.39NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-3193.21Germany
B.1.39NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.39NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1480.18South Korea
B.1.39NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.39NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-2113.71Japan
B.1.39NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.1.39NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.39NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.39NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-2770.32China
B.1.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-3888.18US
B.1.39NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.444NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
B.1.444NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4914.61China
B.1.444NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.444NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-22126.5Thailand
B.1.444NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.444NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
B.1.444NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-2586.25US
B.1.444NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1668.53US
B.1.444NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F92.4864US
B.1.444NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-5669.88US
B.1.444NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-1648.07Singapore
B.1.444NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1906.48Singapore
B.1.444NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-5467.16Germany
B.1.444NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-3342.44Germany
B.1.444NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-3484.59South Korea
B.1.444NWon-NGTTGCGACTACGTGATGAGG20552884928830R-941.915South Korea
B.1.444NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
B.1.444NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-2319.66Japan
B.1.444NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-893.215Hong Kong
B.1.444NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-4478.8Hong Kong
B.1.444NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-3660.47China
B.1.444NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-4360.53China
B.1.444NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.444NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AW.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
AW.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
AW.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
AW.1NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-22126.5Thailand
AW.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
AW.1NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
AW.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AW.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AW.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
AW.1NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
AW.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
AW.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AW.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AW.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used